BioCentury
ARTICLE | Product Development

Carisma adds support for CAR macrophage platform with preclinical data

April 12, 2021 9:34 PM UTC

Carisma is boosting confidence in its CAR macrophage platform ahead of its first clinical readout with preclinical data supporting the cell therapy’s differentiated activity against solid tumors. 

The company presented a trio of abstracts at the 2021 American Association for Cancer Research (AACR) annual meeting, including one that describes mechanistic details about how CAR macrophages may function against heterogeneous solid tumors. ...